Trialsoxytocinvasopressinfmriclinicaltrials.gov

Chinese trial tests oromucosal oxytocin and vasopressin lollipops in fMRI study

The randomized placebo-controlled study compares 24 IU doses delivered through the oral mucosa on attention to emotional faces.

By Priya Raman · Science Reporter

Sep 24 08:00 ETSource: ClinicalTrials.gov

The wire

01NCT07838493, sponsored by the University of Electronic Science and Technology of China, began 18 September 2026 and is recruiting healthy adults for 24 IU oxytocin, 24 IU vasopressin or placebo via a lyophilized oromucosal lollipop.
02Oromucosal delivery is an alternative to the intranasal route that dominates oxytocin research, relevant to anyone tracking social and mood neuropeptides.
03Endpoints are behavioral response time, accuracy, fMRI activity and peripheral neuropeptide levels in healthy volunteers; no clinical population or enrollment number is given.

From the source

Oromucosal Oxytocin and Vasopressin Modulation of Emotional Face Attention
NCT07838493 · NA · RECRUITING · Sponsor: University of Electronic Science and Technology of China · Conditions: Healhty.

Read at clinicaltrials.gov

Source URL https://clinicaltrials.gov/study/NCT07838493